Business
Topcon invests in Sanro Health
Latest strategic investment involves the Sanro Optimizer, which integrates EMR and imaging data to rapidly identify eligible participants for clinical trials.Business
Leadership update: ImprimisRx gets new CEO, BioTissue forms MAB
Leadership changes are underway in the eyecare space—and we’ve got the latest.Business
EssilorLuxottica purchases RetinAI
Ikarian subsidiary is the developer of the FDA-cleared Discovery platform, an AI-based imaging data management system for diagnosing and monitoring ophthalmic disease progression.Pipeline
Complement Therapeutics' GA gene therapy IND receives FDA clearance
Clearance gives green light to begin Q1 2026 patient enrollment for the Opti-GAIN study evaluating CTx001 as a one-time, durable treatment.Business
Topcon officially debuts the Institute for Digital Health
Oculomics company features an AI-based analytics platform designed to provide fast and secure access to real-world and clinical trial datasets.Pipeline
Dompé receives FDA priority voucher for NAION intranasal therapy
New expedited pilot program cuts the standard application review time for investigational candidates from 10 to 12 months to just 1 to 2 months.Products
Haag-Streit USA launches METIS 3D Digital Heads-Up Module
Debut marks an expansion to the METIS 900 ophthalmic microscope system.Business
Topcon purchases Toku, Inc
Acquisition supports ongoing Healthcare from the Eye initiative with a portfolio of AI-based diagnostic and retinal imaging technology.Research
Lower AMD risk tied to long-term metformin use
Study joins growing body of research on the protective effect of metformin against AMD risk in diabetic patients.Products
FDA approves Glaukos' Epioxa corneal CXL therapy
Second-generation CXL therapy is now the first FDA-approved topical drug therapy that does not require removal of the corneal epithelium.Pipeline
Nanoscope's optogenetic therapy demonstrates visual improvements for Stargardt
Findings from phase 2 STARLIGHT trial support the safety and efficacy of MCO-010 in Stargardt disease.Products
Lumenis unveils updates to Digital Duet SLT+YAG platform
Version 2.0 builds on the advancements of the first and only all-in-one digital dual path system of its kind on the market.Products
Optos unveils advanced Silverstone RGB UWF imaging system
Debuting at AAO, the ultra-widefield imaging platform delivers nine imaging modalities—the broadest spectrum of retinal imaging capabilities available for clinicians.Products
ZEISS showcases CLARUS 700 with ICGA for UWF imaging
The updated FDA-cleared fundus camera now offers FDA + ICG simultaneous image capture as well as an added movie mode for all angiography modalities.Research
Physical activity tied to decreased glaucoma progression
Study highlights several ways that exercise may reduce the risk of progression in POAG patients.Products
Alcon unveils updated LenSx OnAxis tech for astigmatism management
New tech enables advanced features such as capsular toric markings, advanced fragmentation patterns, as well as intra- and postoperative IOL verification.Pipeline
FDA grants IDE approval for Avisi's glaucoma treatment device
IDE approval enables initiation of the open-label SAPPHIRE to evaluate the VisiPlate, an aqueous shunt designed to lower IOP among OAG patients.Products
Haag-Streit USA to debut new slit lamp and digital phoropter
company is offering a first look at the Elara 900 and Refractor 900 during this year’s AAO meeting.Products
Iantrek launches AlloFlow Uveo in the US
Bio-interventional surgical implant targets the uveoscleral pathway to enhance aqueous flow (and lower IOP) in glaucoma patients.Products